cycloheximide has been researched along with Glaucoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y; Liu, Y; Wu, X | 1 |
| Do, YJ; Jang, KH; Kang, NS; Kim, E; Kim, YG; Kim, YH; Sul, JW | 1 |
| Garcia-Valenzuela, E; Shareef, S; Sharma, SC; Walsh, J | 1 |
3 other study(ies) available for cycloheximide and Glaucoma
| Article | Year |
|---|---|
Carboxymethylated chitosan alleviated oxidative stress injury in retinal ganglion cells via IncRNA-THOR/IGF2BP1 axis.
Topics: Antioxidants; Apoptosis; Axons; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Cycloheximide; Glaucoma; Humans; Hydrogen Peroxide; Oxidative Stress; Retinal Ganglion Cells; RNA-Binding Proteins; RNA, Long Noncoding; Signal Transduction | 2021 |
A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model.
Topics: Animals; Apoptosis; Cell Hypoxia; Cells, Cultured; Cycloheximide; Disease Models, Animal; Glaucoma; Glucose; HT29 Cells; Humans; Injections, Intraperitoneal; Ischemia; Male; Mice; Mitochondria; Necrosis; Neuroprotection; Oligopeptides; Oxygen; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Retinal Degeneration; Retinal Neurons; Tumor Necrosis Factor-alpha | 2017 |
Programmed cell death of retinal ganglion cells during experimental glaucoma.
Topics: Animals; Apoptosis; Cycloheximide; DNA Nucleotidylexotransferase; Glaucoma; Intraocular Pressure; Rats; Rats, Wistar; Retinal Ganglion Cells | 1995 |